Cormorant Asset Management, LP Heron Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $2.54 Million - $3.93 Million	-150,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$23.15 - $28.34 $363,038 - $444,427	-15,682 Reduced 9.47%	150,000 $3.67 Million
Q4 2018 Feb 14, 2019	SELL	$22.03 - $32.01 $95,125 - $138,219	-4,318 Reduced 2.54%	165,682 $4.3 Million
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $633,240 - $862,261	-21,108 Reduced 11.05%	170,000 $5.38 Million
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $163,879 - $256,089	-8,892 Reduced 4.45%	191,108 $5.28 Million
Q4 2017 Feb 14, 2018	SELL	$14.8 - $18.85 $5.48 Million - $6.97 Million	-370,000 Reduced 64.91%	200,000 $3.62 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $8.35 Million - $9.6 Million	570,000	570,000 $9.21 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.